50 Ug Pegylated Recombinant Erythropoietin Injection

Name: 50 Ug Pegylated Recombinant Erythropoietin Injection
Brand: NEETCO BIOPHARMA
Price: 2499 INR
Availability: InStock

Price 2499 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

50 Ug Pegylated Recombinant Erythropoietin Injection Specification

Assay
50 mcg per 0.3ml

Molecular Formula
C815H1317N233O241S5 (approximate for EPO protein)

Appearance
Clear, colorless to slightly yellowish solution

Pacakaging (Quantity Per Box)
1 Prefilled Syringe

Melting Point
Not Applicable (biological protein)

Physical Form
Liquid Injection

Suitable For
Adults

Dosage Guidelines
As directed by physician

Solubility
Soluble in aqueous solution

Purity
>99% (as protein content)

CAS No
113427-24-0

HS Code
30021500

Type
Biopharmaceutical

Ingredients
PEGylated Recombinant Human Erythropoietin

Feature
Long-acting recombinant erythropoietin

Shelf Life
24 Months

Storage Instructions
Store at 2C to 8C; Do not freeze

Primary Packaging
Thermoform tray with syringe and leaflet

Strength
50 mcg / 0.3 mL

Compatibility
Do not mix with other drugs

Caution
For single use only; discard any unused portion

Container Material
Medical-grade glass or plastic syringe

Protein Source
Chinese Hamster Ovary (CHO) cells (recombinant production)

Pharmacopoeia Standard
Complies with IP/USP requirements

Administration Route
Subcutaneous or Intravenous

Prescription Status
Prescription Only (Rx)

Indication
Treatment of Anemia associated with chronic renal failure

Pack Type
Prefilled Syringe, ready to use

Bioactivity
Comparable to endogenous erythropoietin

Formulation
Sterile, preservative-free

Patient Population
Adults, patients with chronic renal failure or on dialysis

About 50 Ug Pegylated Recombinant Erythropoietin Injection

50 Ug Pegylated Recombinant Erythropoietin Injection, featured for its long-acting profile, is a preeminent biopharmaceutical treatment for anemia associated with chronic renal failure, as remarked upon in favorable reviews across clinical settings. Produced from CHO cells using advanced recombinant techniques, this sterile, preservative-free injection offers uncommon reliability and purity (>99%). Available in a ready-to-use prefilled syringe, it complies with IP/USP standards and should be administered either subcutaneously or intravenously, strictly under physician guidance. Redeem the full therapeutic benefit by adhering to directed dosage and single-use safety protocols.

Usage Directions & Distinct Advantages

Administer 50 Ug Pegylated Recombinant Erythropoietin Injection as directed by a qualified physician, either subcutaneously or intravenously. The prefilled syringe ensures precise dosage and minimizes contamination risks, making it remarkably safe and convenient. Its PEGylated, long-acting formulation allows for sustained bioactivity and fewer injections, a significant advantage over conventional treatments. Single-use packaging and compliance with pharmaceutical standards highlight its unparalleled quality for adults dealing with chronic renal failure.

Export Markets, Packing, and Transactions

The 50 Ug Pegylated Recombinant Erythropoietin Injection is extensively dispatched from India, targeting main export markets such as Asia, the Middle East, and Africa. Each shipped good is securely packaged in a thermoform tray with a prefilled syringe and product leaflet, ensuring optimal condition throughout transportation. Sale price options are available upon inquiry, with standard payment terms including advance and wire transfer, guaranteeing reliability from order to delivery.

FAQ's of 50 Ug Pegylated Recombinant Erythropoietin Injection:

Q: How should the 50 Ug Pegylated Recombinant Erythropoietin Injection be administered?

A: This injection is to be administered subcutaneously or intravenously as directed by a physician. Always use the prefilled syringe for a single dose and discard any remaining solution.

Q: What distinguishes this injection from other erythropoietin products?

A: It features a PEGylated long-acting formulation, offering sustained efficacy, reduced frequency of injections, and a sterile, preservative-free solution manufactured to stringent IP/USP standards.

Q: When should this medicine be used in the treatment cycle?

A: It is prescribed for adults with anemia associated with chronic renal failure, including those on dialysis, to be used according to the physician's indicated schedule.

Q: Where is the product distributed and how is it packaged for export?

A: It is distributed throughout India and major global export markets. Each unit is packed in a thermoform tray containing a single prefilled syringe and an instruction leaflet, ensuring safety during shipment.

Q: What are the benefits of using a prefilled syringe format?

A: The prefilled syringe simplifies accurate dosing, improves convenience, reduces contamination risks, and supports single-use safety protocols, ensuring reliable administration every time.

Tell us about your requirement